Yale Cardiovascular Medicine Grand Rounds: "Harnessing iPSC-derived Cardiac Progenitor Cells and Fibroblasts for Myocardial Repair"

Objectives:

1. Understand the general outcomes from clinical cardiac cell therapy trials performed to date.
2. Appreciate the different cell sources tested for cardiac repair.
3. Describe relevant cardiovascular cell types differentiated from human iPS cells and their applications in cardiac repair.